The mobile units address critical access barriers by bringing FDA-approved targeted therapy directly to local clinics and communities through equipped RVs.

Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...